Full-Time

Senior Migration Consultant

R&D

Confirmed live in the last 24 hours

Veeva Systems

Veeva Systems

5,001-10,000 employees

Quality and regulatory software solutions provider

Compensation Overview

$90k - $185k/yr

+ Variable Bonus + Stock Bonus

Senior

Company Historically Provides H1B Sponsorship

Dallas, TX, USA

Qualified U.S.- and Canada-based applicants who are in close proximity to an airport and able to meet travel requirements are encouraged to apply.

Category
Bioinformatics
Public Health
Biology & Biotech
Required Skills
SAP Products
Salesforce
REST APIs
Oracle
Requirements
  • 7+ years of experience with document/content migration experience with enterprise content management systems (Documentum, OpenText, Box, SharePoint, etc.)
  • 7+ years of experience with database migration with enterprise software systems (SAP, Salesforce.com, PeopleSoft, Oracle, Trackwise, Argus, ArisGlobal, etc.)
  • 7+ years of experience with customer-facing technical consulting experience
  • Proven track record meeting with senior management and executives as the subject matter expert
  • Experience leading and mentoring team members
  • Experience working with REST APIs, JSON, and XML
  • Ability to travel up to 10%
  • Must be both located in and legally authorized to be employed in the United States or Canada
Responsibilities
  • Provide subject matter expertise on the Vault R&D migration implementation, including the migration of document content and object data from legacy systems to Vault
  • Advise customers on the extract, transform, and load (ETL) process
  • Mentor Veeva Data Migration Specialists on migration activities and best practices
  • Contribute to our Professional Services knowledge base to build a migration program
  • Provide guidance and subject-matter-expertise on migration tool development for the ETL process
  • Assist in project scoping estimates for the Vault R&D product suite
Desired Qualifications
  • Experience in the pharmaceutical and life sciences industry
  • Experience with Clinical, Regulatory, Quality, or Safety business processes
  • Project Management experience for enterprise software implementations
  • Experience with GxP and software validation regulations
  • Experience with migration verification process

Veeva Systems offers software solutions for quality, regulatory, and advertising claims management, focusing on consumer products and chemical companies. Their cloud-based platform provides visibility and traceability throughout the product journey, ensuring compliance with regulations and accelerating time-to-market. Unlike competitors, Veeva has expanded from the Life Sciences sector to also serve the Chemical and Consumer Goods markets. The company's goal is to modernize the product journey for clients while operating on a subscription-based model that ensures continuous updates and support.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Pleasanton, California

Founded

2007

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven analytics in life sciences boosts demand for Veeva's cloud solutions.
  • Personalized medicine trends align with Veeva's flexible, scalable software offerings.
  • Blockchain integration in supply chains enhances Veeva's product traceability features.

What critics are saying

  • Emerging cloud software providers threaten Veeva's market share in life sciences.
  • Rapid tech advancements may strain Veeva's resources to innovate continuously.
  • Data privacy concerns could impact Veeva's operations and customer trust.

What makes Veeva Systems unique

  • Veeva Systems specializes in cloud-based software for the life sciences industry.
  • The company offers end-to-end visibility and traceability in product journeys.
  • Veeva's subscription model ensures continuous updates and improvements for clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Parental leave

PTO

Free food

Health, dental, & vision insurance

Gym membership reimbursement

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
PR Newswire
May 30th, 2025
Veeva To Present At Upcoming Investor Conferences

PLEASANTON, Calif., May 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences:Baird 2025 Global Consumer, Technology & Services Conference, New York, NY. Paul Shawah , EVP Strategy, is presenting on Tuesday, June 3, 2025 , at 10:50 a.m. Eastern Time .EVP Strategy, is presenting on , at. William Blair 45th Annual Growth Stock Conference, Chicago, IL. Brian Van Wagener , CFO, is presenting on Wednesday, June 4, 2025 , at 1:20 p.m. Central Time .The above presentations will be webcast

StocksToTrade
May 29th, 2025
Veeva Systems Stock Surge: What's Next?

Advancements in AI integration were announced as Veeva introduced the Veeva AI initiative, aiming to enhance productivity and automate life sciences tasks through their Vault platform.

PR Newswire
May 29th, 2025
Veeva Pulse Report Finds Content-Driven Engagement Lags Despite Proven Boost To Treatment Adoption

Content effectiveness, not creation, is the goal that drives highest impactBARCELONA, Spain, May 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today released the latest insights from its Veeva Pulse Field Trends Report, showing effective content-driven engagement remains one of the top drivers of new treatment adoption — not just content generation. While AI is helping speed content creation at scale, data shows that focusing on the right materials accelerates treatment starts, expands access, reduces time between meetings, and increases the likelihood of a follow-up conversation

PR Newswire
May 28th, 2025
Veeva Announces Fiscal 2026 First Quarter Results

Total Revenues of $759.0M, up 17% Year Over YearSubscription Services Revenues of $634.8M, up 19% Year Over Year. PLEASANTON, Calif., May 28, 2025  /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2025. "I consider this our best first quarter ever. We executed with speed, quality, and innovation across all areas on short-term objectives and long-term initiatives aligned to our values and 2030 goals," said CEO Peter Gassner. "Thanks to the Veeva team for your outstanding work and to our customers for your partnership."

PR Newswire
May 27th, 2025
Biopharma Leaders Connect To Advance Development And Manufacturing At Veeva Rd And Quality Summit Europe

Keynotes from Bayer, Lonza, MSD, Novo Nordisk, Recipharm, and Teva will showcase how connected platforms and AI can streamline the development of new medicinesBARCELONA, May 27, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the biopharma keynote speakers for Veeva R&D and Quality Summit, Europe, June 4-5 in Madrid, Spain. Biopharma professionals will convene to learn how the industry is advancing across clinical, regulatory, safety, and quality. The opening keynote will also highlight Veeva AI, a major initiative to add AI to the Veeva Vault Platform and Veeva applications to help automate critical functions and improve productivity.As one of the largest gatherings of life sciences leaders in Europe, Veeva R&D and Quality Summit will bring together over 1,400 industry professionals in more than 100 sessions. Novo Nordisk and Recipharm will join Rik Van Mol, senior vice president of R&D and Quality, and Avril England, general manager of Veeva Vault, for the opening keynote to explore the development and manufacturing of new medicines and therapies.The event's zone keynotes include:Bayer , discussing how it is streamlining its clinical infrastructure with a customer-centric approach to working with sites, discussing how it is streamlining its clinical infrastructure with a customer-centric approach to working with sites Lonza , a leading CDMO, sharing how the evolving industry ecosystem is reshaping quality management across partners, a leading CDMO, sharing how the evolving industry ecosystem is reshaping quality management across partners MSD , discussing how it is innovating its pharmacovigilance operations and improving efficiency by building a trusted data foundation, discussing how it is innovating its pharmacovigilance operations and improving efficiency by building a trusted data foundation Novo Nordisk , sharing how it accelerates clinical trials and launches by uniting business and IT on Veeva Development Cloud to enhance collaboration, automation, and data consistency, sharing how it accelerates clinical trials and launches by uniting business and IT on Veeva Development Cloud to enhance collaboration, automation, and data consistency Teva, highlighting how innovation, agility, and a data-driven mindset are helping it navigate regulatory change and drive efficiency"Fresh thinking and a strong community are essential to transforming how we bring medicines to patients," says Rik Van Mol, senior vice president of R&D and Quality. "At Veeva R&D and Quality Summit, leaders come together to spark new ideas, share breakthroughs, and shape the future of the industry together."Veeva R&D and Quality Summit is open exclusively to life sciences professionals. Register and review the agenda at veeva.com/eu/Summit.Additional InformationConnect with Veeva on LinkedIn: linkedin.com/company/veeva-systemsAbout Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry